Revised code to increase investor confidence: promote it on your website
Biotechnology companies are urged to display their adherence to the ‘Code of Best Practice for Reporting by Life Science Companies’ on the company website - either on the front page or on the investor relations landing page.
The code has recently been revised and updated in consultation with the ASX and industry experts. An online endorsement ‘button’ for the use of companies that have implemented the code is available free of charge to indicate to investors that the company seeks to disclose according to best practice in accordance with the code, thus giving investors assurance in the life science business.
The code aims to support the directors and management of Australian ASX-listed life science companies to adopt international best practice in reporting events to investors. It also seeks to provide investors with a level of confidence through providing guidance on disclosure and appropriate reporting, as well as educational support regarding clinical trials and other matters.
More information can be found at www.ausbiotech.org/biotechboards.
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
